Viewing Study NCT01147393


Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2026-03-31 @ 11:24 PM
Study NCT ID: NCT01147393
Status: TERMINATED
Last Update Posted: 2018-02-22
First Post: 2010-06-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma
Sponsor: Weill Medical College of Cornell University
Organization: